Tysabri
adults with relapsing forms of multiple sclerosis (MS) to slow the worsening of symptoms and to decrease the number of relapses Crohn’s disease Tysabri has proved to significantly slow the progression of physical disability over a period of 12 weeks. The therapy also reduces the formation of new active sclerotic brain lesions and reduces the […]
Venofer
iron deficiency anemia in patients with chronic kidney disease Venofer is an iron replacement product that is administered by intravenous infusion for at least 15 minutes. Patients choose Red Bank Infusion Center of our flexible, worry-free scheduling, with evening and weekend appointments available our all-private infusion suites, with the latest COVID safety standards in place […]
VYEPTI
adults with chronic migraine Vyepti is indicated as a preventive treatment of migraine in adults. The recommended dosage is 100 mg administered by intravenous infusion every 3 months. Some patients may benefit from a dosage of up to 300 mg administered by intravenous infusion every 3 months. Patients choose Red Bank Infusion Center of our […]
Inflectra
moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease moderately to severely active rheumatoid arthritis psoriatic arthritis plaque psoriasis ankylosing spondylitis Inflectra is a biosimilar medication to Remicade. Inflectra works to block the action of the immune protein TNF-alpha that influences the inflammation that causes symptoms. Inflectra is administered via infusion, usually […]
Benlysta
adults with active systemic lupus erythematosus (“SLE” or “Lupus”) who are receiving other medicines for lupus Benlysta is a biologic infusion therapy that treats active systemic lupus erythematosus (SLE or “Lupus”) in patients who are receiving other medicines for lupus. Benlysta works by reducing certain cells in the immune system that can make lupus more […]
Actemra
moderately to severely active rheumatoid arthritis (RA) who has had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) giant cell arteritis (GCA) active polyarticular juvenile idiopathic arthritis active systemic juvenile idiopathic arthritis Actemra, also known as tocilizumab, is a biologic infusion therapy indicated to treat rheumatoid arthritis. Ultimately, Actemra reduces inflammation. Actemra […]
